Phenotype versus Genotype in Gliomas Displaying Inter- or Intratumoral Histological Heterogeneity

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4841-4851

  Walker, Carol ^a   Du Plessis, Daniel G ^b,c   Joyce, Kathy A ^a   Machell, Yvonne ^a   Thomson Hehir, Joanne ^a   Al Haddad, Syed A ^c   Broome, John C ^b   Warnke, Peter C ^b,c  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASTROCYTOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CAPILLARY ELECTROPHORESIS; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; GENE LOCATION; GENE LOSS; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; TECHNIQUE; TISSUE SECTION; TUMOR DIFFERENTIATION;

ALLELES; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 19; DISEASE PROGRESSION; GENES, P53; GENETIC MARKERS; GENOTYPE; GLIOMA; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MUTATION; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 0142157123     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Prados, M. D., and Levin, V. Biology and treatment of malignant glioma. Semin. Oncol., 27: 1-10, 2000.
2. Bauman, G. S., and Cairncross, J. G. Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligoastrocytomas. Semin. Radiat. Oncol., 11: 170-180, 2001.
3. Fuller, C. E., and Perry, A. Pathology of low- and intermediate-grade gliomas. Semin. Radiat. Oncol., 11: 95-102, 2001.
4. Fortin, D., Cairncross, G. J., and Hammond, R. R. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery, 45: 1279-1291; discussion 1191, 1999.
5. Kleihues, P., and Cavanee, W. K. Pathology and genetics of tumors of the nervous system. Lyon, France: IARC Press, 2000.
6. Bigner, S. H., Rasheed, B. K., Wiltshire, R., and McLendon, R. E. Morphologic and molecular genetic aspects of oligodendroglial neoplasms. Neuro-Oncol., 1: 52-60, 1999.
7. Perry, A. Oligodendroglial neoplasms: current concepts, misconceptions, and folklore. Adv. Anat. Pathol., 8: 183-199, 2001.
8. Giannini, C., Scheithauer, B. W., Weaver, A. L., Burger, P. C., Kros, J. M., Mork, S., Graeber, M. B., Bauserman, S., Buckner, J. C., Burton, J., Riepe, R., Tazelaar, H. D., Nascimento, A. G., Crotty, T., Keeney, G. L., Pernicone, P., and Altermatt, H. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J. Neuropathol. Exp. Neurol., 60: 248-262, 2001.
9. Cavanee, W. K., Bigner, D. D., E. W., N., Paulus, W., and Kleihues, P. Diffuse astrocytomas. In: P. Kleihues, W. K. Cavanee, (eds.), Pathology and Genetics of Tumors of the Nervous System, pp. 22-26. Lyon, France: IARC Press, 1997.
10. Reifenberger, G., Kros, J. M., Schiffer, D., and Collins, V. P. Mixed gliomas. In: P. Kleihues, W. K. Cavanee, (eds.), Pathology and Genetics of Tumors of the Nervous System, pp. 45-48.
11. Kleihues, P., Davis, R. L., Oghaki, H., and Cavanee, W. K. Low-grade diffuse astrocytomas. In: P. Kleihues, W. K. Cavanee, (eds.), Pathology and Genetics of Tumors of the Nervous System, pp. 10-14. Lyon, France: IARC Press, 1997.
12. Smith, J. S., and Jenkins, R. B. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front. Biosci., 5:D213-231, 2000.
13. Perry, J. R. Oligodendrogliomas: clinical and genetic correlations. Curr. Opin. Neurol., 14: 705-710, 2001.
14. Louis, D. N., Holland, E. C., and Cairncross, J. G. Glioma classification: a molecular reappraisal. Am. J. Pathol., 159: 779-786, 2001.
15. Reifenberger, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., and Collins, V. P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol., 145: 1175-1190, 1994.
16. Bello, M. J., Leone, P. E., Vaquero, J., de Campos, J. M., Kusak, M. E., Sarasa, J. L., Pestana, A., and Rey, J. A. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int. J. Cancer, 64: 207-210, 1995.
17. Kraus, J. A., Koopmann, J., Kaskel, P., Maintz, D., Brandner, S., Schramm, J., Louis, D. N., Wiestler, O. D., and von Deimling, A. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J. Neuropathol. Exp. Neurol., 54: 91-95, 1995.
18. Mueller, W., Hartmann, C., Hoffmann, A., Lanksch, W., Kiwit, J., Tonn, J., Veelken, J., Schramm, J., Weller, M., Wiestler, O. D., Louis, D. N., and von Deimling, A. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am. J. Pathol., 161: 313-319, 2002.
19. Maintz, D., Fiedler, K., Koopmann, J., Rollbrocker, B., Nechev, S., Lenartz, D., Stangl, A. P., Louis, D. N., Schramm, J., Wiestler. O. D., and von Deimling, A. Molecular genetic evidence for subtypes of oligoastrocytomas. J. Neuropathol. Exp. Neurol., 56: 1098-1104, 1997.
20. Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., Ramsay, D. A., and Louis, D. N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst., 90: 1473-1479, 1998.
21. Bauman, G. S., Ino, Y., Ueki, K., Zlatescu, M. C., Fisher, B. J., Macdonald, D. R., Stitt, L., Louis, D. N., and Cairncross, J. G. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int. J. Radiat. Oncol. Biol. Phys., 48: 825-830, 2000.
22. Sasaki, H., Zlatescu, M. C., Betensky, R. A., Johnk, L. B., Cutone, A. N., Cairncross, J. G., and Louis, D. N. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade " oligodendroglioma". J. Neuropathol. Exp. Neurol., 61: 58-63, 2002.
23. Hoang-Xuan, K., He, J., Huguet, S., Mokhtari, K., Marie, Y., Kujas, M., Leuraud, P., Capelle, L., Delattre, J. Y., Poirier, J., Broet, P., and Sanson, M. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology, 57: 1278-1281, 2001.
24. Ino, Y., Zlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Jhung, S., Ramsay, D. A., von Deimling, A., Louis, D. N., and Cairncross, J. G. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J. Neurosurg., 92: 983-990, 2000.
25. Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O'Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., and Jenkins, R. B. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J. Clin. Oncol., 18: 636-645, 2000.
26. Ino, Y., Betensky, R. A., Zlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Ramsay, D. A., Cairncross, J. G., and Louis, D. N. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res., 7: 839-845, 2001.
27. Schmidt, M. C., Antweiler, S., Urban, N., Mueller, W., Kuklik, A., Meyer-Puttlitz, B., Wiestler, O. D., Louis, D. N., Fimmers, R., and von Deimling, A. Impact of genotype and morphology on the prognosis of glioblastoma. J. Neuropathol. Exp. Neurol., 61: 321-328, 2002.
28. Tada, K., Shiraishi, S., Kamiryo, T., Nakamura, H., Hirano, H., Kuratsu, J., Kochi, M., Saya, H., and Ushio, Y. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. J. Neurosurg., 95: 651-659, 2001.
29. Terada, K., Tamiya, T., Daido, S., Kambara, H., Tanaka, H., Ono, Y., Matsumoto, K., Ito, S., Ouchida, M., Ohmoto, T., and Shimizu, K. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas. J. Neurooncol., 58: 107-114, 2002.
30. Dong, Z. Q., Pang, J. C., Tong, C. Y., Zhou, L. F., and Ng, H. K. Clonality of oligoastrocytomas. Hum. Pathol., 33: 528-535, 2002.
31. Kattar, M. M., Kupsky, W. J., Shimoyama, R. K., Vo, T. D., Olson, M. W., Bargar, G. R., and Sarkar, F. H. Clonal analysis of gliomas. Hum. Pathol., 28: 1166-1179, 1997.
32. Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., and DePinho, R. A. Malignant glioma: genetics and biology of a grave matter. Genes Dev., 15: 1311-1333, 2001.
33. Misra, A., Chattopadhyay, P., Dinda, A. K., Sarkar, C., Mahapatra, A. K., Hasnain, S. E., and Sinha, S. Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations. J. Neurooncol., 48: 1-12, 2000.
34. Shuangshoti, S., Navalitloha, Y., Kasantikul, V., and Mutirangura, A. Genetic heterogeneity and progression in different areas within high-grade diffuse astrocytoma. Oncol. Rep., 7: 113-117, 2000.
35. Loeper, S., Romeike, B. F., Heckmann, N., Jung, V., Henn, W., Feiden, W., Zang, K. D., and Urbschat, S. Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas. Cytogenet. Cell Genet., 94: 1-8, 2001.
36. Burger, P. C. What is an oligodendroglioma? Brain Pathol., 12: 257-259, 2002.
37. Walker, C., Joyce, K., Du Plessis, D., MacHell, Y., Sibson, D. R., and Broome, J. Molecular genetic analysis of archival gliomas using diagnostic smears. Neuropathol. Appl. Neurobiol., 26: 441-447, 2000.
38. Walker, C., Joyce, K. A., Thompson-Hehir, J., Davies, M. P., Gibbs, F. E., Halliwell, N., Lloyd, B. H., Machell, Y., Roebuck, M. M., Salisbury, J., Sibson, D. R., Du Plessis, D., Broome, J., and Rossi, M. L. Characterisation of molecular alterations in microdissected archival gliomas. Acta Neuropathol. (Berl.), 101: 321-333, 2001.
39. Iqbal, M., Shoker, B. S., Foster, C. S., Jarvis, C., Sibson, D. R., and Davies, M. P. Molecular and genetic abnormalities in radial scar. Hum. Pathol., 33: 715-722, 2002.
40. Thompson-Hehir, J., Davies, M. P., Green. J. A., Halliwell, N., Joyce, K. A., Salisbury, J., Sibson, D. R., Vergote, I., and Walker, C. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors. Diagn. Mol. Pathol., 9: 110-119, 2000.
41. Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., and Cavenee, W. K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol., 61: 215-225; discussion 226-219, 2002.
42. Watanabe, T., Nakamura, M., Kros, J. M., Burkhard, C., Yonekawa, Y., Kleihues, P., and Ohgaki, H. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol. (Berl.), 103: 267-275, 2002.
43. Wistuba, I. I., Berry, J., Behrens, C., Maitra, A., Shivapurkar, N., Milchgrub, S., Mackay, B., Minna, J. D., and Gazdar, A. F. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin. Cancer Res., 6: 2604-2610, 2000.
44. Jung, V., Romeike, B. F., Henn, W., Feiden, W., Moringlane, J. R., Zang, K. D., and Urbschat, S. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J. Neuropathol. Exp. Neurol., 58: 993-999, 1999.
45. Kros, J. M., van Run, P. R., Alers, J. C., Avezaat, C. J., Luider, T. M., and van Dekken, H. Spatial variability of genomic aberrations in a large glioblastoma resection specimen. Acta Neuropathol. (Berl.), 102: 103-109, 2001.
46. Harada, K., Nishizaki, T., Ozaki, S., Kubota, H., Ito, H., and Sasaki, K. Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res., 58: 4694-4700, 1998.
47. Cavanee, W. K., Furnari, F. B., Nagane, M., Huang, H-J. S., E. W., N., Bigner, D. D., Weller, M., M. E., B., Plate, K. H., Israel, M., Noble, M. D., and Kleihues, P. Diffusely infiltrating astrocytomas. In: P. Kleihues, W. K. Cavanee (eds.), Pathology and Genetics of Tumors of the Nervous System, pp. 10-21. Lyon, France: IARC Press, 2000.
48. Reifenberger, G., Kros, J. M., Burger, P., Louis, D. N., and Collins, V. P. Oligodendroglioma. In: P. Kleihues, W. K. Cavanee (eds.), Pathology and Genetics of Tumors of the Nervous System, pp. 56-67. Lyon, France: IARC Press, 2000.
49. Kleihues, P., and Ohgaki, H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-Oncol., 1: 44-51, 1999.
50. Biernat, W., Aguzzi, A., Sure, U., Grant, J. W., Kleihues, P., and Hegi, M. E. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J. Neuropathol. Exp. Neurol., 54: 651-656, 1995.
51. Reis, R. M., Konu-Lebleblicioglu, D., Lopes, J. M., Kleihues, P., and Ohgaki, H. Genetic profile of gliosarcomas. Am. J. Pathol., 156: 425-432, 2000.
52. Actor, B., Cobbers, J. M., Buschges, R., Wolter, M., Knobbe, C. B., Reifenberger, G., and Weber, R. G. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer, 34: 416-427, 2002.
53. Cheng, Y., Ng, H. K., Ding, M., Zhang, S. F., Pang, J. C., and Lo, K. W. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. J. Neuropathol. Exp. Neurol., 58: 120-128, 1999.
54. Fujisawa, H., Kurrer, M., Reis, R. M., Yonekawa, Y., Kleihues, P., and Ohgaki, H. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am. J. Pathol., 155: 387-394, 1999.
55. Jeuken, J. W., Sprenger, S. H., Wesseling, P., Macville, M. V., von Deimling, A., Teepen, H. L., van Overbeeke, J. J., and Boerman, R. H. Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J. Neuropathol. Exp. Neurol., 58: 606-612, 1999.
56. He, J., Mokhtari, K., Sanson, M., Marie, Y., Kujas, M., Huguet, S., Leuraud, P., Capelle, L., Delattre, J. Y., Poirier, J., and Hoang-Xuan, K. Glioblastomas with an oligodendroglial component: a pathological and molecular study. J. Neuropathol. Exp. Neurol., 60: 863-871, 2001.
57. Kraus, J. A., Lamszus, K., Glesmann, N., Beck, M., Wolter, M., Sabel, M., Krex, D., Klockgether, T., Reifenberger, G., and Schlegel, U. Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol. (Berl.), 101: 311-320, 2001.
58. Alvord, E. C., Jr. Is necrosis helpful in the grading of gliomas? Editorial opinion. J. Neuropathol. Exp. Neurol., 51: 127-132, 1992.
59. Burger, P. C., Rawlings, C. E., Cox, E. B., McLendon, R. E., Schold, S. C., Jr., and Bullard, D. E. Clinicopathologic correlations in the oligodendroglioma. Cancer (Phila.), 59: 1345-1352, 1987.
60. Burger, P. C., Pearl, D. K., Aldape, K., Yates, A. J., Scheithauer, B. W., Passe, S. M., Jenkins, R. B., and James, C. D. Small cell architecture-a histological equivalent of EGFR amplification in glioblastoma multiforme? J. Neuropathol. Exp. Neurol., 60: 1099-1104, 2001.